04.11.2016 • NewsDede WillamsAustraliaCompetition

Australia Weighs in on DowDuPont

(c) DOW
(c) DOW

In its first weigh-in on the proposed merger of US chemical giants Dow and DuPont into DuPontDow, the Australian Competition and Consumer Commission (ACCC) has expressed concern about the transaction’s effect on competition for a diverse range of products, including insecticides, seeds and material science products.As Dow and DuPont may be the only suppliers or potential suppliers of ionomer and acid co-polymer materials to plastics manufacturers in Australia, the merger would remove competition between them, potentially to the detriment of Australian customers,” said ACCC Chairman Rod Sims.

The regulatory agency chairman said the proposed merger also could reduce the competitive tension in the research and development of new crop protection products and thus slow the introduction of new products into the market. This is especially significant, he said, where pests have developed resistance to older chemical controls.

Sims noted also that the ACCC intends to take a closer look at Dow and DuPont's existing overlap in a large number of product areas. Market inquiries, he said, “have raised particular concerns about certain competing patented insecticides for chewing and sucking pests.”

Another area where the authority plans to intensely scrutinize the plans is the merger’s potential long-term effect on in canola seed innovation in Australia. Both US chemical producers are active in the research and development of new canola seed varieties adapted to Australian conditions. DuPont recently sold the supply side of its seed business, Sims explained, but retained the R&D functions. Dow has not yet released canola seed in Australia but has announced plans to do so.

Sims said the ACCC “is liaising closely with overseas competition regulators, as many of these potential competition issues arise in other countries as well.” Up to Nov. 24, the agency is inviting further submissions from interested parties in response to the Statement of Issues published in the Australian public register. Australia plans to announce its final decision on the merger plans on Feb. 2, 2017. The EU’s verdict is expected around the same time. 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.